Deep Dive: Drug Prices and Access to Medicine
Full Session
Setup
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs doubled from 2013 to 2014. That puts them far out of reach for countess ailing people, including many with decent insurance. The industry argues that it needs the revenue for the complex and expensive research that leads to better treatments, but pharmaceutical executives are being pilloried in editorials and Congressional hearings, and consumer groups say marketing and profit are the real drivers of price. What’s behind the cost of drugs? What are the options for people who can’t pay it?
Speakers
-
Kenneth L. DavisPresident and CEO, Mount Sinai Health System (Festival Underwriter); T... -
Alan WeilEditor in Chief, Health Affairs -
Kiah WilliamsCo-Founder and Director, SIRUM -
Lisa GillDeputy Content Editor, Best Buy Drugs, Consumer Reports (Festival Unde... -
Ezekiel EmanuelVice Provost for Global Initiatives, Diane v. S. Levy and Robert M. Le... -
Geoffrey ChaikenCo-Founder and CEO, Blink Health -
Kirsten AxelsenVice President Global Policy, Pfizer (Festival Underwriter)
Explore More
Health
Rick Doblin wants to be a legally licensed psychedelic therapist. Learn about his work using MDMA, or ecstasy, to help people suffering from PTSD.
What would happen if genetic sequencing were standard care for undiagnosed diseases? And how can we ensure that the future of genomics benefits everyone, not just the one perc...
Artificial intelligence is working its way deeper into our lives. Intelligent systems are reading and responding to human emotions, playing a critical role in medicine, and ga...
While all emotions are valid, their usefulness might ultimately come down to how well a person is able to interpret the signals that their feelings provide.
Musician Yoko Sen remembered listening to the beeping and the chaos when she was in the hospital and wondering if those were the last sounds she would ever hear.
